Clinical Trials Consumption Packaging THC 
Cannabis Law Report
JUNE 4, 2021
We believe there is a benefit to Delta-8 but there should be labeling or warnings on packages so that consumers are informed of potential minor intoxication effects. It’s no surprise to InfiniteCAL that Delta 8-THC is becoming more regulated every day, and we believe that it should be regulated nationwide.
Cannabis Law Report
JULY 23, 2019
Businesses preparing to market a new product nationally must follow the rules of trademark law as well as marketing and advertising claims under state and US laws when creating a trademark, advertising copy and copyright-registered packaging for the product. This is particularly the case for cannabis and cannabidiol (CBD) products.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
OCTOBER 19, 2021
A clinical trial published in 2015 found that the test subjects had “significantly higher blood THC” levels when they used cannabis along with alcohol, and combining the two led to increased performance impairment. A 2010 study found that consuming alcohol “slightly prolonged” the half-life of THC in the blood.
Otherside Farms
JANUARY 16, 2019
Microdosing, if you have not yet heard of it, is hotter than just any ordinary trend: Science proves THC and CBD safe, with very real benefits associated with consuming very low doses regularly, as opposed to massive doses all at once. When one talks of a microdose, THC content is no more than a measly 2.5 Expectations for Microdosing.
Cannabis Law Report
MARCH 29, 2020
According to Vividata’s National Cannabis Consumer Study , 70% of consumers are not sure they know the difference between THC and CBD. Canada’s largest syndicated study of cannabis consumers reveals that price remains a top barrier to legal cannabis consumption. . Authored By: Arundati Dandapani.
Cannabis Law Report
OCTOBER 29, 2019
Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval.
Expert insights. Personalized for you.
105 
Let's personalize your content